The Bright Beginnings program has been awarded a $50,000 grant from the Community Foundation for Greater New Haven to expand its support services for vulnerable inner-city women and their babies. The program, which pairs trained volunteers with pregnant women, aims to promote good health care and parenting practices.
The Donaghue Foundation has awarded Yale a five-year, $6.5 million grant to enhance its leadership role in women's health research. The program aims to support original and interdisciplinary research projects that address understudied aspects of women's health.
Research by Dr. Dan A. Oren may help alleviate SAD symptoms such as fatigue, sadness, weight gain, and sleep problems. His study suggests that blood absorbs light energy from the sun, regulating biological clocks and behavior.
A recent study by Yale University School of Medicine researchers found that nearly 30% of people over 72 years old regained their ability to perform essential activities of daily living. The strongest predictor of recovery was age, with participants aged 85 or younger being more likely to regain independent ADL function.
A Yale study reveals that information related to faces is processed in a specific region of the prefrontal cortex. The research found that neurons responding to faces were clustered in one area, called the inferior prefrontal cortex, and were able to maintain activity even after stimuli disappeared.
A 12-year study found that attending religious services was associated with healthier behaviors, stronger social ties, and improved emotional well-being in elderly individuals. The study revealed that religious attendance acted as a linchpin for overall health practices, friendships, and leisure activities.
Engineered Salmonella bacteria, stripped of pathogenicity, target solid tumors in laboratory animals while having little or no adverse effects. The safe versions can significantly prolong the life of mice with melanoma.
Scientists at Yale University School of Medicine have discovered a link between the drug phencyclidine (PCP) and cognitive deficits in schizophrenia. The study found that PCP induces similar cognitive dysfunction as that found in patients diagnosed with schizophrenia, but also suggests potential for reversal using clozapine.